Community acquired pneumonia: an increased risk for subsequent cardiovascular events? Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021
QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
To identify mortality rate and related factors in respiratory care unit patients Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP? Source: Eur Respir J 2004; 23: 103-105 Year: 2004
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007
Reduction in acute hospital resource use by patients with severe COPD: an integrated facilitated care model Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019
A dedicated COPD team reduces mortality in patients with type 2 respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 312s Year: 2004
Telemonitoring in outpatients with COPD: a retrospective analysis of the effect on exacerbation rate, hospital admission and overall healthcare consumption using myCOPDcoach Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020
The impact of a definition when assessing the cumulative incidence of exacerbation for a primary care cohort of COPD patient Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Analysis of patients with COPD requiring mechanical ventilation: characteristics, outcomes and risk factors for hospital mortality Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009
Enhanced care services to reduce unplanned admissions in high risk COPD patients are ready for extensive deployment Source: Annual Congress 2008 - Nursing interventions in the management of COPD and dyspnoea Year: 2008
Who are the patients who die of COPD with no evidence of prior diagnosis? A UK primary care database analysis. Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases Year: 2020
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Treatment changes, readmission rates and mortality in a COPD hospital at home scheme Source: Eur Respir J 2005; 26: Suppl. 49, 286s Year: 2005